Tobias A. Werner
Duesseldorf, NW 40225, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Multitargeted Aza-Arylcarboxamides for Neurodegenerative Diseases: Potent Histamine H3 Receptor Ligands with Anticholinesterase and Metal-Chelating Activities.
Journal: ACS chemical neuroscience
Published: January 29, 2026
Design, Synthesis, and Biological Evaluation of Novel Multitarget 7-Alcoxyamino-3-(1,2,3-triazole)-coumarins as Potent Acetylcholinesterase Inhibitors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 12, 2025
Histamine H3 receptor blockade alleviates neuropathic pain through the regulation of glial cells activation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 18, 2024
Virtual Screening Approaches to Identify Promising Multitarget-Directed Ligands for the Treatment of Autism Spectrum Disorder.
Journal: Molecules (Basel, Switzerland)
Published: September 30, 2024
First Report on Cationic Triphenylphosphonium Compounds as Mitochondriotropic H3R Ligands with Antioxidant Properties.
Journal: Antioxidants (Basel, Switzerland)
Published: September 30, 2024
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders.
Journal: Medicinal research reviews
Published: June 06, 2024
First in class pyrrolo[2,3-d]pyrimidine derivatives fused to fluorobenzylpiperidines as dual ligands of acetylcholinesterase and histamine H3 receptor.
Journal: Archiv der Pharmazie
Published: May 17, 2024
4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H3 Receptors and Cholinesterases.
Journal: ACS chemical neuroscience
Published: March 05, 2024
Progress on the development of Class A GPCR-biased ligands.
Journal: British journal of pharmacology
Published: December 11, 2023
Guanidines: Synthesis of Novel Histamine H3R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 10, 2023
Trisubstituted 1,3,5-Triazines as Histamine H4 Receptor Antagonists with Promising Activity In Vivo.
Trisubstituted 1,3,5-Triazines as Histamine H4 Receptor Antagonists with Promising Activity In Vivo.
Journal: Molecules (Basel, Switzerland)
Published: March 30, 2023
Anti-inflammatory effects of new human histamine H3 receptor ligands with flavonoid structure on BV-2 neuroinflammation.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: February 07, 2022
Last Updated: 09/26/2026